Treatment of soft tissue sarcoma: a focus on earlier stages.

View/ Open
Publication Date
2017-01Author
Gronchi, A
Maki, RG
Jones, RL
Type
Journal Article
Metadata
Show full item recordAbstract
Surgery, with or without radiation therapy, is the standard of care for primary soft tissue sarcoma, with adjuvant/neodjuvant chemotherapy playing a role only in high-risk patients. Chemotherapy is generally the principal treatment modality for locally advanced or metastatic disease. Within this context, newer techniques and promising new treatments are challenging traditional treatment paradigms. For example, identification of histology-specific treatments is leading the field toward individualized care, with better outcomes. Patients over 65 years represent a sizable and largely undertreated sector of the soft tissue sarcoma population, with many being unsuited to receive anthracycline- or ifosfamide-based chemotherapy. First-line treatment options in this population are discussed.
Collections
Version of record
Subject
Humans
Sarcoma
Neoplasm Staging
Treatment Outcome
Combined Modality Therapy
Retreatment
Disease Management
Research team
Sarcoma Clinical Trials (R Jones)
Language
eng
License start date
2017-01
Citation
Future oncology (London, England), 2017, 13 (1s), pp. 13 - 21